Literature DB >> 22698178

Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response.

Mieke Gouwy1, Milena Schiraldi, Sofie Struyf, Jo Van Damme, Mariagrazia Uguccioni.   

Abstract

The arrest and directed migration of leukocytes during homeostasis, tumour development and inflammation is orchestrated by a multitude of chemokines, which govern leukocyte migratory activities. Immune cells are particularly adept at adjusting rapidly to changes within the environment by migration in response to chemokines. The confrontation of leukocytes with different combination of chemokines that are concomitantly produced under physiological or pathological conditions in vivo is complex. There are different ways to enhance or reduce leukocyte migration mediated by chemokines such as posttranslational modifications. Here, we described a positive regulatory mechanism in leukocyte trafficking, by the synergism between chemokines to rapidly augment the local leukocyte influx, thereby enhancing the outcome of an inflammatory response in vivo. The cellular mechanisms involved in chemokine synergy are still debated, but probably include chemokine and/or receptor heterodimerization and subsequent cooperation in signal transduction.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698178     DOI: 10.1016/j.imlet.2012.04.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

1.  Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.

Authors:  Federica De Leo; Giacomo Quilici; Mario Tirone; Francesco De Marchis; Valeria Mannella; Chiara Zucchelli; Alessandro Preti; Alessandro Gori; Maura Casalgrandi; Rosanna Mezzapelle; Marco E Bianchi; Giovanna Musco
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

2.  CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister.

Authors:  Gerben Bouma; Stefano Zamuner; Kirsty Hicks; Andrew Want; João Oliveira; Arpita Choudhury; Sara Brett; Darren Robertson; Leigh Felton; Virginia Norris; Disala Fernando; Michael Herdman; Ruth Tarzi
Journal:  Br J Clin Pharmacol       Date:  2017-04-22       Impact factor: 4.335

Review 3.  The unique structural and functional features of CXCL12.

Authors:  Rik Janssens; Sofie Struyf; Paul Proost
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

Review 4.  Chemokines in homeostasis and diseases.

Authors:  Keqiang Chen; Zhiyao Bao; Peng Tang; Wanghua Gong; Teizo Yoshimura; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

5.  The Anti-inflammatory Effect of the CXCR4 Antagonist-N15P Peptide and Its Modulation on Inflammation-Associated Mediators in LPS-Induced PBMC.

Authors:  Xue-mei Mo; Han-xiao Sun
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

6.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 7.  Modulation of Chemokine Responses: Synergy and Cooperativity.

Authors:  Amanda E I Proudfoot; Mariagrazia Uguccioni
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

Review 8.  Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.

Authors:  Valentina Cecchinato; Gianluca D'Agostino; Lorenzo Raeli; Mariagrazia Uguccioni
Journal:  J Leukoc Biol       Date:  2015-12-29       Impact factor: 4.962

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

Review 10.  Chemokines from a Structural Perspective.

Authors:  Michelle C Miller; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.